Immunome, Inc. · NASDAQ:IMNM
The Vanguard Group reported a 5.20% stake in Immunome, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.20% stake in Immunome, Inc., 4,524,952 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 4,524,952
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.20% | 4,524,952 |
Source
Related
- Immunome, Inc.
- The Vanguard Group
- Immunome, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · The Vanguard Group · Jan 30, 2025
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026